Hostname: page-component-848d4c4894-5nwft Total loading time: 0 Render date: 2024-05-12T07:22:48.760Z Has data issue: false hasContentIssue false
  • English
  • Français

Schizophrenia in Covid-19 crisis : Is it a mortality risk factor ?

Published online by Cambridge University Press:  01 September 2022

K. Nourchene ,
E. Khelifa ,
B. Abassi ,
S. Ben Aissa ,
O. Maatouk ,
I. Bouguerra  and
L. Mnif
K. Nourchene*
Affiliation:
Razi hospital, Pedopsychiatry, Tunis, Tunisia Razi hospital, Skolly, Tunis, Tunisia
E. Khelifa
Affiliation:
Razi Hospital, F Adult Psychiatry Department, Manouba, Tunisia
B. Abassi
Affiliation:
Razi Hospital, Psychiatry Ibn Omran, Manouba, Tunisia
S. Ben Aissa
Affiliation:
Hôpital Razi, Psychiatry F, Manouba, Tunisia
O. Maatouk
Affiliation:
Razi Hospital, F Adult Psychiatry Department, Manouba, Tunisia
I. Bouguerra
Affiliation:
Errazi hospital-Mannouba, F, Mannouba, Tunisia
L. Mnif
Affiliation:
Hôpital Razi, Psychiatry F, Manouba, Tunisia
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Patients with mental disorders mainly schizophrenia represent a vulnerable population. In Covid-19 pandemic situation, could schizophrenia be considered as a significant mortality risk factor ?

Objectives

In this study, we aimed to explore the odds of significant COVID-19 mortality among schizophrenia patients

Methods

Our literature review was based on the PubMed interface and adapted for 2 databases: Science Direct and Google Scholar using the following combination ( schizophrenia [MeSH terms]) AND (COVID-19, mortality[MeSH terms])

Results

Our review included 4 population-based cohort studies covering the period from december 2019 to May 2021. The data showed increased mortality risk among individuals with schizophrenia who have had COVID-19. Indeed, this high rate of mortality maybe associated with multiple factors such as unhealthy lifestyle, low socioeconomic status and comorbidities as obesity, diabetes and cardiovascular conditions. The use of antipsychotics can be considered as a risk factor regarded its immunomodulatory effects. Furthermore, stigma and discrimination towards mental illnesses particularly schizophrenia might have contributed to a worse prognosis.

Conclusions

Schizophrenia is a severe mental disorder ,associated with an increased high risk Covid-19. Thus, this population require enhanced preventive and disease management strategies.

Disclosure

No significant relationships.

Keywords

Covid-19schizophréniamortality
Type
Abstract
Information
European Psychiatry , Volume 65 , Special Issue S1: Abstracts of the 30th European Congress of Psychiatry , June 2022 , pp. S512
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of the European Psychiatric Association
Submit a response

Comments

No Comments have been published for this article.